Artificial Intelligence
Announcing the Innovators in Big Idea Ventures’ Latest Accelerator Cohorts
NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) — Big Idea Ventures, global leader in early stage investing in the food technology sector, revealed its latest accelerator cohorts today.
Seventeen early-stage startups were selected for pre-seed investment as part of Big Idea Ventures’ bi-annual accelerator program. Investments were made through the firm’s New York and Singapore offices and the firm’s newest office in Paris, which opened early 2021. Big Idea Ventures’ accelerator is part of its New Protein Fund ($50M+ AUM), dedicated to early stage investments in alternative protein products, ingredients and technologies.
“Innovation in alternative proteins continues to advance globally,” said Andrew D. Ive, Founder and Managing General Partner of Big Idea Ventures, “helping to solve big challenges with big ideas. The entrepreneurs we support have real solutions to climate and food challenges, Big Idea Ventures is investing in the best companies around the world, and these developments could not arrive at a more critical moment for us all.”
The seventeen companies in Big Idea Ventures’ latest accelerator cohorts are developing and improving on protein alternatives across the value chain:
New York Accelerator — Cohort 4
“This year, we’re seeing smart solutions to improve current alternatives and expedite their time to market. Each company in our New York program is addressing at least one barrier to mass-market commercialization, from price and scalability to performance and nutritional content.” — Mia Medicus, Program Director, BIV New York
- Fybraworks Foods — will disrupt the $1.4 trillion traditional ag-based meat market by growing real animal meat proteins via microbes that are cheaper to produce and free of hormones and antibiotics. Fybraworks is the world’s first company to develop recombinant muscle protein for food applications.
- De Novo Dairy — is the first African company to use precision fermentation technology to produce nature identical, animal-free dairy proteins that replicate dairy in function and nutrition allowing for the creation of animal-free cheese, yoghurt and ice cream.
- Prosel Biosciences — leverages high-performance computing to unlock the potential of microalgae to sustainably produce bioidentical food proteins and selenoprotein-modified industrial enzymes. Prosel’s platform technologies are able to express proteins with up to 10x higher yields compared to wild type yields.
- BetterMilk — makes whole milk with mammary cells. BetterMilk’s innovative genetic engineering platform allows for the dramatic reduction in the cost of lactation hormones and growth medium to bring their milk to price parity at launch. They are a B2B company who will sell their milk and milk ingredients to companies from the food, cosmetic and pharmaceutical industry.
- Liven Proteins — produces animal-free, functional protein ingredients by fermenting agriculture and food industry by-products, bringing a circular economy in the food value chain. Liven is developing a platform technology, with gelatin as the first product.
- Maya Milk — uses precision fermentation to produce animal origin-free dairy proteins and fats. Maya Milk’s mission is to create dairy products structurally similar to animal derived counterparts, without compromising the sensory experience that consumers are accustomed to.
Singapore Accelerator — Cohort 4
“Singapore is at the forefront for regulatory approvals and commercialisation of cell-based meats and alternative protein. Our cohort is leading with cutting-edge innovations from indulgent foods, cultivated exotic meat and surimi and a multitude of fermentation solutions to produce sustainable protein.” — Dr. Dalal AlGhawas, Program Director, BIV Singapore
- Phyx44 — is a cellular agriculture startup creating dairy alternatives using precision fermentation. Phyx44 is producing nature-identical, animal free dairy proteins & fats to recreate milk and its derivatives – same taste, healthier & lower carbon footprint.
- LILO — is a New Zealand fruit technology company creating permissibly indulgent snacks from low grade and waste fruit. LILO’s hero product is a ready to eat plant based and gluten free cheesecake that is every bit as indulgent as it’s dairy counterpart. LILO is working directly with New Zealand orchardists and strategic partners to untap the potential in unused produce and create a range of nutritionally superior products for on the go lifestyles.
- Fisheroo — is Southeast Asia’s first cell-based fish company focusing on the $5 billion huge surimi industry, and aims to create surimi at scale and sell it as an ingredient to existing surimi product manufacturers and potentially integrating with innovative plant-based companies. Fisheroo has their proprietary cell line within their state-of-the-art facility based in Singapore and are on track to deliver a prototype within 2022.
- Mogale Meat — is Africa’s first cultivated game meat company, is developing real meat products from southern Africa’s antelope, poultry and free-roaming cattle species, using advanced cellular agriculture technologies. Their proprietary biobank of stem and satellite cell lines is sourced from free-range livestock and wild antelope and poultry species, each valued for their unique flavour and health benefits. By investing in southern Africa’s rich biodiversity with minimal impact, Mogale Meat Co distinguishes itself from existing competitors by expanding culinary diversity of cell cultured meat.
Paris Accelerator — Cohort 1
“The alternative protein industry is growing rapidly in Europe, and we were impressed by the number of quality applicants for Big Idea Ventures first cohort in Paris. From plant-based innovators to novel fatty acid and cell-based technologies, the Paris cohort is a great example of the food innovation coming from Europe.” — Henrietta Hearth, Program Director, BIV Paris
- Bright Biotech — is using cutting edge science to de-bottleneck the supply and reduce the cost of growth factors to speed up the delivery of cell-based meat to our dinner plates. They have developed a robust and scalable plant-based technology that uses chloroplasts as chassis to manufacture large amounts and cost-efficient growth factors.
- Green-On — makes ultra-sustainable saturated fat and fatty acids with their power to food technology, using only carbon dioxide, electricity and a small amount of water. Initially focusing on replacing palm oil to produce chocolate, ready meals and other food products, the technology can be adapted to replace other fats.
- Little Bandits — is the first dairy and soy-free brand for children in the UK. They make life easier for parents and kids by developing products that are always nutritious, delicious and fun. Their yogurts have at least 25% more calcium but 50% less sugar than leading kids dairy yogurts. They are also the first kids yogurts to market to be fortified with calcium, vitamins D2, B12 and iodine.
- Luyef Biotechnologies — is a cell-based meat company using molecular biology and photonics to produce the next generation of cell-based meat. They have already developed a myoglobin protein which delivers the flavour and aroma of real meat for plant-based meat. They are also working on a scaffolding for real cultured minced meat using a macro-algae only found in Chile and are using state-of-the-art neuroscience to produce juicy, three-dimensional cultured meat steaks.
- The VERY Food co. — are enabling change without changing people’s habits in the kitchen by delivering quality plant-based ingredients for cooking : eggs, butter and cream. We address the barriers to switching to an animal-free diet by replicating the taste, texture and appearance of animal-based ingredients used in professional and everyday cooking.
- YOFI — is a French food-tech startup offering a delicious range of organic milk alternatives using sustainable, nutritious and tasty peas to offer good quality drinks with high nutritional value. The use of peas instead of other traditional plant-based ingredients entails a higher amount of proteins, amino acids and unsaturated fatty acids.
- MOA foodtech (France / Singapore Offices) — combines biotechnology and artificial intelligence to transform waste and by-products of the agrifood industry into a ”next generation protein ” with high nutritional value and 100% sustainability. MOA’s technology offers high nutritional proteins based on the valorization of food industry by-products thanks to biotechnology and fermentation processes.
About Big Idea Ventures
Big Idea Ventures (BIV) is solving the world’s greatest challenges by supporting the world’s best entrepreneurs. Its first fund, the New Protein Fund ($50M+ AUM) invests in global alternative protein companies at the pre-seed stage via its accelerator program and seed to series A via direct investment. New Protein Fund I is backed by leading food corporations including AAK, Avril, Bel Group, Bühler Group, Givaudan, NR Instant Produce, Meiji, Tyson Ventures, and Temasek Holdings. To date, Big Idea Ventures has invested in more than 65 alternative protein companies across 17 countries.
www.bigideaventures.com
Big Idea Ventures is currently accepting applications to its next accelerator cohorts in New York, Paris and Singapore, beginning in early 2022: https://bigideaventures.proseeder.com/application/start
Media Contact
Big Idea Ventures
New York — Aaron Brodkey [email protected]
Paris — Marion Bazille [email protected]
Singapore — Yiting Loh [email protected]
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence4 days agoSilent Eight secures AIA as its latest client
-
Artificial Intelligence4 days agoGlobal Networking Innovator Huawei Leads the New Era of Campus Network Technology
-
Artificial Intelligence4 days agoBroadcom Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Delivering Reliable and Flexible Hybrid Cloud Management Solutions
-
Artificial Intelligence2 days agoHuawei Introduces AI Technologies to Accelerate Network Transformation Towards All Intelligence in the Net5.5G Era
-
Artificial Intelligence4 days agoAI Chips and Chat GPT – IDTechEx Explores AI and Robotics
-
Artificial Intelligence4 days agoGFT teams up with Google Cloud to launch ‘GenAI Intelligent Assistant’
